MedCity News January 2, 2022
Frank Vinluan

As in previous years, cancer products topped the list of new FDA-approved therapies in 2021. But the list of drug approvals is notable for other trends, including developments in rare diseases and regenerative medicine.

In 2021, the FDA actions that drew the most attention were not drug approvals. Across the country and around the world people closely followed the regulatory developments of Covid-19 vaccines and therapies on the path to emergency authorization. So far, of the three Covid vaccines that have received emergency authorization, the Pfizer and BioNTech vaccine is the only one that has secured full FDA approval.

That Covid vaccine, named Comirnaty, is one of 60 new drugs or biological products that received FDA approval in 2021. The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Will The White House’s Plan To Curb Drug Shortages Work?
Pharma Pulse 4/24/24: 5 Things You Should Know About Women's Health, Microsoft Makes Push Into Smaller AI Systems & more
World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas
New AI drug discovery powerhouse Xaira rises with $1B in funding
Moderna turns to AI to change how its employees work

Share This Article